BULFAMANTE, SARA
BULFAMANTE, SARA
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis
2017-01-01 Principe, Moitza; Borgoni, Simone; Cascione, Mariafrancesca; Chattaragada, Michelle Samuel; Ferri-Borgogno, Sammy; Capello, Michela; Bulfamante, Sara; Chapelle, Jennifer; Di Modugno, Francesca; Defilippi, Paola; Nisticò, Paola; Cappello, Paola; Riganti, Chiara; Leporatti, Stefano; Novelli, Francesco
Alpha-Enolase (ENO1), a potential target in novel immunotherapies
2017-01-01 Cappello Paola; Principe Moitza; Bulfamante Sara; Novelli Francesco
Antibody and T cell response profiling in pancreatic cancer patients before and after chemotherapy identify tumor associated antigens suitable for immunotherapy
2018-01-01 Sara Bulfamante, Giorgia Mandili, Moitza Principe, Daniele Giordano, Emanuela Mazza, Claudia Curcio, Laura Follia, Giulio Ferrero, Andrea Evangelista, Maria Antonietta Satolli, Paola Cappello, Francesco Novelli
Antibody and T cell response profiling of pancreatic cancer patients before and after chemotherapy reveals increased recognition of antigens suitable for immunotherapy
2017-01-01 Giorgia Mandili, Moitza Principe, Emanuela Mazza, Sara Bulfamante, Laura Follia, Giulio Ferrero, Andrea Evangelista, Daniele Giordano, Paola Cappello, Francesco Novelli
Discovery of Targets for Cancer Immunoprevention
2022-01-01 Cappello P.; Bulfamante S.; Mandili G.; Novelli F.
Identification of chemotherapy-induced antigens suitable for immunotherapy in pancreatic cancer patients
2017-01-01 Sara Bulfamante, Giorgia Mandili, Moitza Principe, Emanuela Mazza, Laura Follia, Giulio Ferrero, Andrea Evangelista, Paola Cappello, Francesco Novelli
In pancreatic cancer chemotherapy increases anti-tumor responses to tumor associated antigens and potentiates DNA vaccination
2020-01-01 Mandili G, Curcio C, Bulfamante S, Follia L, Ferrero G, Mazza E, Principe M, Cordero F, Satolli MA, Spadi R, Evangelista A, Giordano D, Viet D, Cappello P, Novelli F.
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens
2024-01-01 Silvia Brugiapaglia; Sara Bulfamante; Claudia Curcio; Maddalena Arigoni; Raffaele Calogero; Lisa Bonello; Elisa Genuardi; Rosella Spadi; Maria Antonietta Satolli; Donata Campra; Daniele Giordano; Paola Cappello; Francesca Cordero; Francesco Novelli
Next generation immunotherapy for pancreatic cancer: DNA vaccination is seeking new combo partners
2018-01-01 Cappello, Paola; Curcio, Claudia; Mandili, Giorgia; Roux, Cecilia; Bulfamante, Sara; Novelli, Francesco
Profiling small RNAs in fecal immunochemical tests: is it possible?
2023-01-01 Birkeland, Einar; Ferrero, Giulio; Pardini, Barbara; Umu, Sinan U.; Tarallo, Sonia; Bulfamante, Sara; Hoff, Geir; Senore, Carlo; Rounge, Trine B; Naccarati, Alessio
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
2021-01-01 Curcio C.; Brugiapaglia S.; Bulfamante S.; Follia L.; Cappello P.; Novelli F.
Unleashing anti-tumor immune responses in pancreatic cancer by tumor-associated antigens
2021-12-21
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis | 2017 | Principe, Moitza; Borgoni, Simone; Cascione, Mariafrancesca; Chattaragada, Michelle Samuel; Ferri-Borgogno, Sammy; Capello, Michela; Bulfamante, Sara; Chapelle, Jennifer; Di Modugno, Francesca; Defilippi, Paola; Nisticò, Paola; Cappello, Paola; Riganti, Chiara; Leporatti, Stefano; Novelli, Francesco | |
| Alpha-Enolase (ENO1), a potential target in novel immunotherapies | 2017 | Cappello Paola; Principe Moitza; Bulfamante Sara; Novelli Francesco | |
| Antibody and T cell response profiling in pancreatic cancer patients before and after chemotherapy identify tumor associated antigens suitable for immunotherapy | 2018 | Sara Bulfamante, Giorgia Mandili, Moitza Principe, Daniele Giordano, Emanuela Mazza, Claudia Curcio, Laura Follia, Giulio Ferrero, Andrea Evangelista, Maria Antonietta Satolli, Paola Cappello, Francesco Novelli | |
| Antibody and T cell response profiling of pancreatic cancer patients before and after chemotherapy reveals increased recognition of antigens suitable for immunotherapy | 2017 | Giorgia Mandili, Moitza Principe, Emanuela Mazza, Sara Bulfamante, Laura Follia, Giulio Ferrero, Andrea Evangelista, Daniele Giordano, Paola Cappello, Francesco Novelli | |
| Discovery of Targets for Cancer Immunoprevention | 2022 | Cappello P.; Bulfamante S.; Mandili G.; Novelli F. | |
| Identification of chemotherapy-induced antigens suitable for immunotherapy in pancreatic cancer patients | 2017 | Sara Bulfamante, Giorgia Mandili, Moitza Principe, Emanuela Mazza, Laura Follia, Giulio Ferrero, Andrea Evangelista, Paola Cappello, Francesco Novelli | |
| In pancreatic cancer chemotherapy increases anti-tumor responses to tumor associated antigens and potentiates DNA vaccination | 2020 | Mandili G, Curcio C, Bulfamante S, Follia L, Ferrero G, Mazza E, Principe M, Cordero F, Satolli MA, Spadi R, Evangelista A, Giordano D, Viet D, Cappello P, Novelli F. | |
| In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens | 2024 | Silvia Brugiapaglia; Sara Bulfamante; Claudia Curcio; Maddalena Arigoni; Raffaele Calogero; Lisa Bonello; Elisa Genuardi; Rosella Spadi; Maria Antonietta Satolli; Donata Campra; Daniele Giordano; Paola Cappello; Francesca Cordero; Francesco Novelli | |
| Next generation immunotherapy for pancreatic cancer: DNA vaccination is seeking new combo partners | 2018 | Cappello, Paola; Curcio, Claudia; Mandili, Giorgia; Roux, Cecilia; Bulfamante, Sara; Novelli, Francesco | |
| Profiling small RNAs in fecal immunochemical tests: is it possible? | 2023 | Birkeland, Einar; Ferrero, Giulio; Pardini, Barbara; Umu, Sinan U.; Tarallo, Sonia; Bulfamante, Sara; Hoff, Geir; Senore, Carlo; Rounge, Trine B; Naccarati, Alessio | |
| The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer | 2021 | Curcio C.; Brugiapaglia S.; Bulfamante S.; Follia L.; Cappello P.; Novelli F. | |
| Unleashing anti-tumor immune responses in pancreatic cancer by tumor-associated antigens | 2021 | - |